Study selection The criteria for including studies in this meta-analysis were as follows: (1) (i) randomized controlled trials (RCTs) comparing different AOMs with placebo, including glucagon-like peptide 1 receptor agonist (GLP-1 RA), dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 RAs, GLP-1 and glucagon receptor (GCGR) dual-agonist, orlistat, lorcaserin, naltrexone-bupropion, phentermine-topiramate, and bimagrumab
Liu, Tianqi, et al
Moraga F, Janciauskiene S
While clinical trials have shown some promise when it comes to L-carnitine and weight loss, the clinical evidence shows the effects of L-carnitine are generally modest
People think splitting or spacing out their dose might help stretch their supply, Defnet says
He has also served as Chief Medical Officer and Director of Hospital Medicine at New London HospitalDartmouth